市場調查報告書

醫藥品原料藥(API)的全球市場

Active Pharmaceutical Ingredients/API

出版商 Global Industry Analysts, Inc. 商品編碼 892640
出版日期 內容資訊 英文 172 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品原料藥(API)的全球市場 Active Pharmaceutical Ingredients/API
出版日期: 2019年10月01日內容資訊: 英文 172 Pages
簡介

本報告提供全球醫藥品原料藥 (API) 市場相關調查分析,市場概要,市場趨勢,今後預測等相關考察,美國,加拿大,日本,歐洲,亞太地區,全球其他各國的各市場相關分析,主要企業的簡介等相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 醫藥品原料藥概要
    • 醫療產業急劇的成長促進API的需求
    • 企業的全球市場佔有率
    • 全球醫藥品原料藥市場佔有率Scenario
    • 企業的全球市場佔有率:各市場區隔
    • 新開發 (種類)
    • 非專利 (種類)
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 歐洲的其他各國
  • 亞太地區
  • 全球其他各國

第4章 競爭

  • ABBVIE
  • ASTRAZENECA PLC
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • PFIZER
  • TEVA PHARMACEUTICAL INDUSTRIES

第5章 彙整

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP10061

Active Pharmaceutical Ingredients/API market worldwide is projected to grow by US$85.7 Billion, driven by a compounded growth of 5.9%. Innovative, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$102 Billion by the year 2025, Innovative will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$4 Billion to the region's size and clout in the next 5 to 6 years. Over US$4 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Innovative will reach a market size of US$8.9 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.8% over the next couple of years and add approximately US$14.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, AbbVie, Inc.; AstraZeneca PLC; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Pfizer, Inc.; Sanofi; Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Active Pharmaceutical Ingredients: An Overview
  • Rapid Growth of Healthcare Industry Drives Demand for API
  • Global Competitor Market Shares
  • Active Pharmaceutical Ingredients/API Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Factors Influencing the Demand of Active Pharmaceutical Ingredients
  • Gene-Editing - New Techniques Emerging within the Biologics Industry
  • API-in-Capsule Fast-Tracking Drug Development Process

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Active Pharmaceutical Ingredients/API Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Active Pharmaceutical Ingredients/API Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Active Pharmaceutical Ingredients/API Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Innovative (Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Innovative (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Innovative (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Generic (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Generic (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Generic (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Captive (Manufacturer) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Captive (Manufacturer) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Captive (Manufacturer) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Merchant (Manufacturer) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Merchant (Manufacturer) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Merchant (Manufacturer) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Synthetic (Synthesis) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Synthetic (Synthesis) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Synthetic (Synthesis) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Biotech (Synthesis) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Biotech (Synthesis) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Biotech (Synthesis) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Active Pharmaceutical Ingredients/API Market Share (in %) by Company: 2019 & 2025
    • TABLE 22: United States Active Pharmaceutical Ingredients/API Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 23: Active Pharmaceutical Ingredients/API Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 24: United States Active Pharmaceutical Ingredients/API Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 25: United States Active Pharmaceutical Ingredients/API Market Estimates and Projections in US$ Million by Manufacturer: 2018 to 2025
    • TABLE 26: Active Pharmaceutical Ingredients/API Market in the United States by Manufacturer: A Historic Review in US$ Million for 2009-2017
    • TABLE 27: United States Active Pharmaceutical Ingredients/API Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025
    • TABLE 28: United States Active Pharmaceutical Ingredients/API Market Estimates and Projections in US$ Million by Synthesis: 2018 to 2025
    • TABLE 29: Active Pharmaceutical Ingredients/API Market in the United States by Synthesis: A Historic Review in US$ Million for 2009-2017
    • TABLE 30: United States Active Pharmaceutical Ingredients/API Market Share Breakdown by Synthesis: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 31: Canadian Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 32: Canadian Active Pharmaceutical Ingredients/API Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 33: Active Pharmaceutical Ingredients/API Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 34: Canadian Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Manufacturer: 2018 to 2025
    • TABLE 35: Canadian Active Pharmaceutical Ingredients/API Historic Market Review by Manufacturer in US$ Million: 2009-2017
    • TABLE 36: Active Pharmaceutical Ingredients/API Market in Canada: Percentage Share Breakdown of Sales by Manufacturer for 2009, 2019, and 2025
    • TABLE 37: Canadian Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Synthesis: 2018 to 2025
    • TABLE 38: Canadian Active Pharmaceutical Ingredients/API Historic Market Review by Synthesis in US$ Million: 2009-2017
    • TABLE 39: Active Pharmaceutical Ingredients/API Market in Canada: Percentage Share Breakdown of Sales by Synthesis for 2009, 2019, and 2025
  • JAPAN
    • TABLE 40: Japanese Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 41: Active Pharmaceutical Ingredients/API Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 42: Japanese Active Pharmaceutical Ingredients/API Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 43: Japanese Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Manufacturer for the Period 2018-2025
    • TABLE 44: Active Pharmaceutical Ingredients/API Market in Japan: Historic Sales Analysis in US$ Million by Manufacturer for the Period 2009-2017
    • TABLE 45: Japanese Active Pharmaceutical Ingredients/API Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025
    • TABLE 46: Japanese Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Synthesis for the Period 2018-2025
    • TABLE 47: Active Pharmaceutical Ingredients/API Market in Japan: Historic Sales Analysis in US$ Million by Synthesis for the Period 2009-2017
    • TABLE 48: Japanese Active Pharmaceutical Ingredients/API Market Share Analysis by Synthesis: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 49: Chinese Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 50: Active Pharmaceutical Ingredients/API Historic Market Analysis in China in US$ Million by Type: 2009-2017
    • TABLE 51: Chinese Active Pharmaceutical Ingredients/API Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 52: Chinese Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Manufacturer for the Period 2018-2025
    • TABLE 53: Active Pharmaceutical Ingredients/API Historic Market Analysis in China in US$ Million by Manufacturer: 2009-2017
    • TABLE 54: Chinese Active Pharmaceutical Ingredients/API Market by Manufacturer: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 55: Chinese Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Synthesis for the Period 2018-2025
    • TABLE 56: Active Pharmaceutical Ingredients/API Historic Market Analysis in China in US$ Million by Synthesis: 2009-2017
    • TABLE 57: Chinese Active Pharmaceutical Ingredients/API Market by Synthesis: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Active Pharmaceutical Ingredients/API Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • API Supply Chain Overview
    • TABLE 58: European Active Pharmaceutical Ingredients/API Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 59: Active Pharmaceutical Ingredients/API Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 60: European Active Pharmaceutical Ingredients/API Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 61: European Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 62: Active Pharmaceutical Ingredients/API Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 63: European Active Pharmaceutical Ingredients/API Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 64: European Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Manufacturer: 2018-2025
    • TABLE 65: Active Pharmaceutical Ingredients/API Market in Europe in US$ Million by Manufacturer: A Historic Review for the Period 2009-2017
    • TABLE 66: European Active Pharmaceutical Ingredients/API Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025
    • TABLE 67: European Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Synthesis: 2018-2025
    • TABLE 68: Active Pharmaceutical Ingredients/API Market in Europe in US$ Million by Synthesis: A Historic Review for the Period 2009-2017
    • TABLE 69: European Active Pharmaceutical Ingredients/API Market Share Breakdown by Synthesis: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 70: Active Pharmaceutical Ingredients/API Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 71: French Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 72: French Active Pharmaceutical Ingredients/API Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 73: Active Pharmaceutical Ingredients/API Market in France by Manufacturer: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 74: French Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Manufacturer: 2009-2017
    • TABLE 75: French Active Pharmaceutical Ingredients/API Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025
    • TABLE 76: Active Pharmaceutical Ingredients/API Market in France by Synthesis: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 77: French Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Synthesis: 2009-2017
    • TABLE 78: French Active Pharmaceutical Ingredients/API Market Share Analysis by Synthesis: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 79: Active Pharmaceutical Ingredients/API Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 80: German Active Pharmaceutical Ingredients/API Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 81: German Active Pharmaceutical Ingredients/API Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 82: Active Pharmaceutical Ingredients/API Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Manufacturer for the Period 2018-2025
    • TABLE 83: German Active Pharmaceutical Ingredients/API Historic Market Analysis in US$ Million by Manufacturer: 2009-2017
    • TABLE 84: German Active Pharmaceutical Ingredients/API Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025
    • TABLE 85: Active Pharmaceutical Ingredients/API Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Synthesis for the Period 2018-2025
    • TABLE 86: German Active Pharmaceutical Ingredients/API Historic Market Analysis in US$ Million by Synthesis: 2009-2017
    • TABLE 87: German Active Pharmaceutical Ingredients/API Market Share Breakdown by Synthesis: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 88: Italian Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 89: Active Pharmaceutical Ingredients/API Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
    • TABLE 90: Italian Active Pharmaceutical Ingredients/API Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 91: Italian Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Manufacturer for the Period 2018-2025
    • TABLE 92: Active Pharmaceutical Ingredients/API Historic Market Analysis in Italy in US$ Million by Manufacturer: 2009-2017
    • TABLE 93: Italian Active Pharmaceutical Ingredients/API Market by Manufacturer: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 94: Italian Active Pharmaceutical Ingredients/API Market Growth Prospects in US$ Million by Synthesis for the Period 2018-2025
    • TABLE 95: Active Pharmaceutical Ingredients/API Historic Market Analysis in Italy in US$ Million by Synthesis: 2009-2017
    • TABLE 96: Italian Active Pharmaceutical Ingredients/API Market by Synthesis: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 97: United Kingdom Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 98: Active Pharmaceutical Ingredients/API Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 99: United Kingdom Active Pharmaceutical Ingredients/API Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 100: United Kingdom Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Manufacturer for the Period 2018-2025
    • TABLE 101: Active Pharmaceutical Ingredients/API Market in the United Kingdom: Historic Sales Analysis in US$ Million by Manufacturer for the Period 2009-2017
    • TABLE 102: United Kingdom Active Pharmaceutical Ingredients/API Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025
    • TABLE 103: United Kingdom Market for Active Pharmaceutical Ingredients/API: Annual Sales Estimates and Projections in US$ Million by Synthesis for the Period 2018-2025
    • TABLE 104: Active Pharmaceutical Ingredients/API Market in the United Kingdom: Historic Sales Analysis in US$ Million by Synthesis for the Period 2009-2017
    • TABLE 105: United Kingdom Active Pharmaceutical Ingredients/API Market Share Analysis by Synthesis: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 107: Active Pharmaceutical Ingredients/API Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 108: Rest of Europe Active Pharmaceutical Ingredients/API Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 109: Rest of Europe Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Manufacturer: 2018-2025
    • TABLE 110: Active Pharmaceutical Ingredients/API Market in Rest of Europe in US$ Million by Manufacturer: A Historic Review for the Period 2009-2017
    • TABLE 111: Rest of Europe Active Pharmaceutical Ingredients/API Market Share Breakdown by Manufacturer: 2009 VS 2019 VS 2025
    • TABLE 112: Rest of Europe Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Synthesis: 2018-2025
    • TABLE 113: Active Pharmaceutical Ingredients/API Market in Rest of Europe in US$ Million by Synthesis: A Historic Review for the Period 2009-2017
    • TABLE 114: Rest of Europe Active Pharmaceutical Ingredients/API Market Share Breakdown by Synthesis: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 115: Active Pharmaceutical Ingredients/API Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 116: Asia-Pacific Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 117: Asia-Pacific Active Pharmaceutical Ingredients/API Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 118: Active Pharmaceutical Ingredients/API Market in Asia-Pacific by Manufacturer: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 119: Asia-Pacific Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Manufacturer: 2009-2017
    • TABLE 120: Asia-Pacific Active Pharmaceutical Ingredients/API Market Share Analysis by Manufacturer: 2009 VS 2019 VS 2025
    • TABLE 121: Active Pharmaceutical Ingredients/API Market in Asia-Pacific by Synthesis: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 122: Asia-Pacific Active Pharmaceutical Ingredients/API Historic Market Scenario in US$ Million by Synthesis: 2009-2017
    • TABLE 123: Asia-Pacific Active Pharmaceutical Ingredients/API Market Share Analysis by Synthesis: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 124: Rest of World Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 125: Rest of World Active Pharmaceutical Ingredients/API Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 126: Active Pharmaceutical Ingredients/API Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 127: Rest of World Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Manufacturer: 2018 to 2025
    • TABLE 128: Rest of World Active Pharmaceutical Ingredients/API Historic Market Review by Manufacturer in US$ Million: 2009-2017
    • TABLE 129: Active Pharmaceutical Ingredients/API Market in Rest of World: Percentage Share Breakdown of Sales by Manufacturer for 2009, 2019, and 2025
    • TABLE 130: Rest of World Active Pharmaceutical Ingredients/API Market Estimates and Forecasts in US$ Million by Synthesis: 2018 to 2025
    • TABLE 131: Rest of World Active Pharmaceutical Ingredients/API Historic Market Review by Synthesis in US$ Million: 2009-2017
    • TABLE 132: Active Pharmaceutical Ingredients/API Market in Rest of World: Percentage Share Breakdown of Sales by Synthesis for 2009, 2019, and 2025

IV. COMPETITION

  • ABBVIE
  • ASTRAZENECA PLC
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRISTOL-MYERS SQUIBB COMPANY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • PFIZER
  • TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Back to Top